sea-maid submitted, created time 5 months 3 weeks (sciencenow.sciencemag.org)

Breast cancer patients with a mutation in both copies of the NQO1 gene have a 20% lower survival rate five years after treatment than do patients without the mutation, according to a new study of more than 2000 Finnish women.

1 comment | Blog It | Email It | Keywords: enzymes chemotherapy epirubicin cancer women women's health NQO1 mutations breast cancer NQO1 gene